Pharmaceutical compositions comprising fentanyl for intranasal delivery

Details for Australian Patent Application No. 2004204381 (hide)

International Classifications

Event Publications

28 July 2005 PCT application entered the National Phase

PCT publication WO2004/062561 Priority application(s): WO2004/062561

22 September 2005 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 04 Jul 2005

25 November 2010 Application Accepted

Published as AU-B-2004204381

24 March 2011 Standard Patent Sealed

13 September 2012 Extension of Term of Standard Patents

Archimedes Development Limited The earliest first regulatory approval date provided by the patentee 13 Aug 2012 Extensions of Term of Standard Patents Extension of Term of a Standard Patent relating to Pharmaceutical Substances Applications Filed For the goods PECFENT fentanyl (as fentanyl citrate)

1 November 2012 Extension of Term of Standard Patents

Archimedes Development Limited The earliest first regulatory approval date provided by the patentee 13 Aug 2012 For the goods PECFENT fentanyl (as fentanyl citrate) Address for service in Australia: Griffith Hack GPO Box 1285 Melbourne VIC 3001

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.